MicroStockProfit.com announces an investment report featuring Hansen Medical Inc. (Nasdaq:HNSN). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Hansen Medical, Inc. (HNSN) develops, manufactures and sells generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to instinctively navigate flexible catheters with greater stability and control in interventional procedures. The Company's focus is on electrophysiology (EP) procedures for the diagnosis and treatment of patients who suffer from abnormal heart rhythms, or arrhythmias, such as atrial fibrillation. In addition to its development efforts in the treatment of atrial arrhythmias, the Company is also investigating other EP applications, such as ventricular tachycardia and left atrial appendage occlusion.
Message Board Search for HNSN: http://www.boardcentral.com/boards/HNSN
In the report, the analyst notes:
"The Company expects first-quarter revenues to be in the range of $2.5 million to $2.7 million. Revenues for the quarter are expected to include recognition of revenue for one Sensei system previously deferred from a prior period and for the shipment of 624 Artisan(TM) catheters at an average sales price of approximately $1,660. The expected range and components of 2010 first-quarter revenues are estimates and are subject to change.
"HNSN and Siemens Healthcare yesterday announced joint development and cooperation agreements to co-develop integrated products designed to help simplify complex cardiac procedures for the diagnosis and treatment of cardiac arrhythmias, or irregular heartbeats."
To read the entire report visit: www.microstockprofit.com/ads/HNSN
Periodontal treatment after heart rhythm ablation may reduce AFib recurrence